Clinical Trial Update: Safety and Efficacy of GW685698X an Inhaled Corticosteroid Once Daily and Twice Daily for the Treatment of Asthma [Phase 2]

View source ↗

Summary

Phase 2 trial assessing GW685698X, an inhaled corticosteroid, in asthma reports safety and efficacy for both once-daily and twice-daily dosing. Results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• GW685698X

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2013-08-07